(Press-News.org) Cancer therapies that target specific genetic abnormalities in tumors have revolutionized treatment possibilities over the past two decades. While quality of life and survival are improved with targeted therapies, relapse is common due to the evolution of new tumor cells that are resistant to the targeted therapy. A new study by investigators from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, reveals how lung tumors may develop drug resistance over time, pointing to a protein, called APOBEC3A, that could be a promising target. Results, published in Nature, may help researchers develop new solutions for tumor resistance to targeted cancer therapies.
“Traditionally, we treat patients with a drug until the tumor progresses and then we look at what happened in the tumor and try to decide on the next therapy based on what we see in the tumor,” said corresponding author Aaron Hata, MD, PhD, of the Mass General Cancer Center. “In that sense, the tumor is always one step ahead and we need to react to it. By understanding the fundamental mechanisms of tumor evolution, we can get ahead of the tumor, understand what’s driving it, and be able to intervene earlier.”
In this study, the authors analyzed non-small-cell lung cancer (NSCLC) tumor cells treated with tyrosine kinase inhibitors (TKIs), a type of targeted therapy. The researchers performed genetic analysis on patient tumors as well as experimentally derived TKI-resistant cells, finding that in both settings, the small population of tumor cells that survived after TKI treatment accumulated mutations of the APOBEC mutation signature. The authors found that the tumor cells surviving TKI treatment overexpress a type of APOBEC protein, APOBEC3A, which appears to cause drug resistance in two main ways. APOBEC3A can directly cause mutations that are known to result in tumor resistance, such as mutations in the ALK gene. In other cases, the cause of drug resistance is less direct, though the researchers hypothesize that APOBEC3A causes extensive DNA damage that helps push tumor cells into a "persister" state that is more resistant to treatment.
The researchers demonstrated that cell lines without the APOBEC3A gene did not become resistant to targeted therapies as fast as those with the gene. This suggests that targeting APOBEC could extend patients’ response to existing targeted therapies; however, no drug exists yet to target APOBEC.
Going forward, the researchers hope to gain further insight into the mechanisms by which APOBEC causes drug resistance, which may shed more light on how to develop a drug to inhibit APOBEC expression or activity. While many NSCLC patients with targeted therapy-resistant tumors have APOBEC mutations, the patients that do not have these mutations would require other solutions. Furthermore, it is not yet clear whether APOBEC drives acquired drug resistance in other cancer types or with use of other targeted therapies.
“Many new cancer therapies that have been developed in the genomic era specifically target ‘driver mutations,’ such that they do not hurt healthy cells and only affect cells with the mutation driving the tumor progression,” said corresponding author Michael Lawrence, PhD, of the Mass General Cancer Center. “Very often, however, a tumor will return, having undergone a change that allows it to survive in the presence of the drug. Our research helps us understand the mechanisms that drive the process of drug resistance, which begin before the tumor becomes resistant.”
Disclosures: Hata has received grants/research support from Amgen, Blueprint Medicines, BridgeBio, Bristol-Myers Squibb, C4 Therapeutics, Eli Lilly, Novartis, Nuvalent, Pfizer, Roche/Genentech and Scorpion Therapeutics; and has served as a compensated consultant for Engine Biosciences, Nuvalent, Oncovalent, TigaTx and Tolremo Therapeutics. A full list of disclosures is available in the article.
Funding: This study was funded by support from the National Institutes of Health (K08 CA197389, R01 CA249291, R37 CA252081, R01 CA137008, R01 CA164273, U01CA220323, and P50 CA265826); by the Doris Duke Charitable Foundation Clinical Scientist Development Award, Smith Family Foundation Award, Rullo Family Innovation Award, SU2C/NSF/V Foundation Convergence Award, the Ludwig Center at Harvard, Tosteson & FMD Award, Lung Cancer Research Foundation, the Lungstrong Foundation, Targeting a Cure for Lung Cancer, Be a Piece of the Solution, the Landry Family and the Suzanne E. Coyne Family.
Paper cited: Isozaki, H et al. “Therapy-induced APOBEC3A drives evolution of persistent cancer cells” Nature DOI: 10.1038/s41586-023-06303-1
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Cancer Center, a member of Mass General Brigham, is an integral part of one of the world’s most distinguished academic medical centers and is consistently ranked by U.S. News & World Report as one of the top cancer centers in the country. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
NEW YORK, NY-- A new study suggests that eye drops developed by Columbia University researchers could be a more effective–and comfortable–therapy for a common eye disease currently treated with injections into the eye.
Retinal vein occlusion (RVO), an eye disease that affects up to 2% of people over age 40, occurs when a vein in the eye’s retina becomes blocked, leading to swelling in the eye, inflammation, damage to the retina, and vision loss.
Standard therapy involves injecting into the eye a vascular endothelial growth factor inhibitor (anti-VEGF) that reduces swelling. ...
Scientists at the University of Texas Institute for Geophysics (UTIG) have developed a radar technique that lets them image hidden features within the upper few feet of ice sheets. The researchers behind the technique said that it can be used to investigate melting glaciers on Earth as well as detect potentially habitable environments on Jupiter’s moon Europa.
The near-surface layers of ice sheets are difficult to study with airborne or satellite ice-penetrating radar because much of what’s scientifically important happens too close to the surface to be accurately imaged. ...
New Haven, Conn. — Simply the smell of seafood can make those with an allergy to it violently ill — and therefore more likely to avoid it. The same avoidance behavior is exhibited by people who develop food poisoning after eating a certain meal.
Scientists have long known that the immune system played a key role in our reactions to allergens and pathogens in the environment, but it was unclear whether it played any role in prompting these types of behaviors towards allergic triggers.
According to Yale-led research published July ...
NEWPORT, Ore. – Rates of Chinook salmon bycatch in the Pacific hake fishery rise during years when ocean temperatures are warmer, a signal that climate change and increased frequency of marine heatwaves could lead to higher bycatch rates, new research indicates.
During years when sea surface temperatures were higher, including during a marine heatwave, Chinook salmon were more likely to overlap with the Pacific hake and raise the risk of bycatch as they sought refuge from higher temperatures.
The findings, based on ...
July 12, 2023
Bacterium Associated With Disease Found in N.C. Chiggers
EMBARGOED FOR RELEASE UNTIL NOON EDT ON WEDNESDAY, JULY 12
A bacterium that causes a disease called scrub typhus – a disease not previously reported in the United States – has been detected in North Carolina, according to a new study by researchers at North Carolina State University and UNC-Greensboro.
The researchers stress that scrub typhus, which can cause fever, headache and body aches – and can be fatal if left untreated by antibiotics – has not yet been ...
Researchers at McLean and Mass General Hospital demonstrated that a transplant surgical procedure (called “needle trauma”) triggers a profound immune response and causes the death of most grafted dopamine neurons
They also found that co-transplantation of neuronal cell therapy with host regulatory T cells resulted in effective suppression of needle trauma and significant improvement in the survival and recovery of grafts
Findings suggest a path for the ‘realistic’ use of cell therapy to treat neurodegenerative disorders
Cell therapy holds promise as a new treatment for Parkinson’s disease but, in many trials to date, most transplanted dopamine ...
About The Study: This study found that the joint exposure of unequal income distribution and lack of social mobility was associated with additional risks for deaths of despair (deaths from suicide, drug overdose, and alcohol-related liver disease), suggesting that addressing the underlying social and economic conditions is crucial in responding to the epidemic of deaths of despair.
Authors: Chun-Tung Kuo, Ph.D., of National Taiwan University in Taipei, is the corresponding author.
To access the embargoed study: Visit our ...
About The Study: Into the second year of the pandemic, mental health emergency department visits increased notably among adolescent females, and there was an increase in prolonged boarding (waiting in an emergency department or medical inpatient unit) of youth awaiting inpatient psychiatric care. Interventions are needed to increase inpatient child psychiatry capacity and reduce strain on the acute mental health care system.
Authors: Haiden A. Huskamp, Ph.D., of Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2023.2195)
Editor’s ...
CAMBRIDGE, MA -- The ocean’s color has changed significantly over the last 20 years, and the global trend is likely a consequence of human-induced climate change, report scientists at MIT, the National Oceanography Center in the U.K., and elsewhere.
In a study appearing today in Nature, the team writes that they have detected changes in ocean color over the past two decades that cannot be explained by natural, year-to-year variability alone. These color shifts, though subtle to the human eye, have occurred over 56 percent of the world’s oceans — an expanse that is larger than ...
Like its viral cousins, a somewhat parasitic DNA sequence called a retrotransposon has been found borrowing the cell’s own machinery to achieve its goals.
In a new work appearing online Wednesday in the journal Nature, a Duke University team has determined that retrotransposons hijack a little-known piece of the cell’s DNA repair function to close themselves into a ring-like shape and then create a matching double strand.
The finding upends 40 years of conventional wisdom saying these rings were just a useless by-product of bad gene copying. It may also offer new insights into cancer, viral infections and immune responses.
Retrotransposons are segments ...
